Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis.

Abstract

BACKGROUND:

Glutathione-S transferases (GSTs) comprise a series of critical enzymes involved in detoxification of endogenous or xenobiotic compounds. Among several GSTs, Glutathione S-transferases mu (GSTM) has been implicated in a number of cancer types. However, the prognostic value and potential functions of the GSTM family genes have not been investigated in lung adenocarcinoma (LUAD).

METHODS:

We examined the expression of GSTM5 in LUAD and identified associations among GSTM5 expression, clinicopathological features, survival data from the Cancer Genome Atlas (TCGA). The correlation between GSTM5 DNA methylation and its expression was analyzed using the MEXPRESS tool and UCSC Xena browser. The methylation status of GSTM5 in the promoter region in lung cancer cells was measured by methylation-specific PCR (MSP). After 5-aza-2'-deoxycytidine treatment of lung cancer cells, expression of GSTM5, cell proliferation and migration were assessed by RT-PCR, CCK-8 and transwell assays, respectively.

RESULTS:

The results showed that GSTM5 was abnormally down-regulated in LUAD patients' tissues, and patients with low GSTM5 expression level had significantly shorter OS. Cox regression analyses revealed that GSTM5 was associated with overall survival (OS) of LUAD patients, which expression was an independent prognostic indicator in terms of OS (hazard ratio: 0.848; 95% CI: 0.762-0.945; P = 0.003). In addition, we found the promoter region of GSTM5 was hypermethylated in the tumor tissue compared with adjacent normal tissues, and the average methylation level of GSTM5 were moderately correlated with its expression. Moreover, methylation-specific PCR also showed that the GSTM5 gene promoter was hypermethylated in lung cancer cells, and treatment with 5-Aza-CdR can restore the gene expression and inhibit cell proliferation and migration. Finally, Gene Set Enrichment Analysis (GSEA) revealed that low GSTM5 expression was significantly related to DNA repair pathways.

CONCLUSION:

Our data demonstrate that low GSTM5 expression and its high DNA methylation status may act as a novel putative molecular target gene for LUAD.

• Authors: Xuewei Hao, Jun Zhang, Guoyou Chen, Weiwei Cao, Hongyang Chen, Shuo Chen
• Journal: BMC cancer (BMC Cancer) Vol. 22 Issue 1 Pg. 685 (Jun 21 2022) ISSN: 1471-2407 [Electronic] England
• PMID: 35729618 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s).

Chemical References

• Biomarkers, Tumor
• Decitabine
• DNA
• Transferases
• GSTM5 protein, human
• Glutathione Transferase
• Glutathione

Topics

• Adenocarcinoma of Lung (pathology)
• Biomarkers, Tumor (genetics, metabolism)
• DNA (metabolism)
• DNA Methylation
• Decitabine
• Gene Expression Regulation, Neoplastic
• Glutathione (metabolism)
• Glutathione Transferase
• Humans
• Lung Neoplasms (pathology)
• Prognosis
• Transferases (genetics, metabolism)